ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,149.78
0.16%
Dow Jones
43,002.88
-0.75%
Gold vs US Dollar
2,618.89
-0.53%
Brent Oil
73.725
1.15%
Bitcoin
94,453.56
-1.28%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) News

Femasys (FEMY)

Femasys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateTimeSourceHeadlineSymbolCompany
03/12/202414:00GlobeNewswire Inc.Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeedNASDAQ:FEMYFemasys Inc
26/11/202413:30GlobeNewswire Inc.Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility TreatmentNASDAQ:FEMYFemasys Inc
12/11/202421:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FEMYFemasys Inc
12/11/202413:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
12/11/202413:30GlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
07/11/202413:30GlobeNewswire Inc.Femasys to Exhibit at the Annual AAGL 2024 Global ConferenceNASDAQ:FEMYFemasys Inc
01/11/202412:30GlobeNewswire Inc.Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNASDAQ:FEMYFemasys Inc
30/10/202413:00GlobeNewswire Inc.Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeedNASDAQ:FEMYFemasys Inc
29/10/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
10/10/202412:30GlobeNewswire Inc.Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education ProgramNASDAQ:FEMYFemasys Inc
08/10/202412:30GlobeNewswire Inc.Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitNASDAQ:FEMYFemasys Inc
02/10/202412:30GlobeNewswire Inc.Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsNASDAQ:FEMYFemasys Inc
18/09/202412:30GlobeNewswire Inc.Femasys Announces Infertility Clinic Customers from Coast to CoastNASDAQ:FEMYFemasys Inc
11/09/202412:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
11/09/202412:30GlobeNewswire Inc.Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish MarketNASDAQ:FEMYFemasys Inc
09/09/202412:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
09/09/202412:30GlobeNewswire Inc.Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube CheckNASDAQ:FEMYFemasys Inc
05/09/202412:30GlobeNewswire Inc.Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual MeetingNASDAQ:FEMYFemasys Inc
03/09/202412:30GlobeNewswire Inc.Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FEMYFemasys Inc
30/08/202420:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
29/08/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
29/08/202412:30GlobeNewswire Inc.Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment SolutionNASDAQ:FEMYFemasys Inc
27/08/202412:30GlobeNewswire Inc.Femasys Hosts Congresswoman Lucy McBath at Georgia HeadquartersNASDAQ:FEMYFemasys Inc
08/08/202412:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
08/08/202412:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
08/08/202412:30GlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
15/07/202420:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
15/07/202420:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
15/07/202420:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
15/07/202420:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Your Recent History

LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
UPS
LSE
GEX
Georgina Energy
LSE
GDR
Genedrive
LSE
TRP
Tower Resources
LSE
SRT
Srt Marine Systems
LSE
DEC
Diversified Energy
LSE
MIN
Minoan
LSE
RPI
Raspberry Pi
LSE
VTY
Vistry
LSE
BIRD
Blackbird
LSE
SRSP
Sirius Petroleum
LSE
BARC
Barclays
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads